TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -2 | -15 | -26 | -38 | -53 | -23 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/23 16:05 | 5/21/23 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nies Alan S | TX | D | M.d | 0 | 0.00 | 0 | 9 | 29 | 41 | D | |||||||||||||||
5/2/22 16:16 | 4/30/22 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nies Alan S | TX | D | M.d | 0 | 0.00 | 0 | 4 | 15 | 32 | D | |||||||||||||||
4/27/21 16:48 | 4/24/21 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nies Alan S | TX | D | M.d | 0 | 0.00 | 0 | 11 | 62 | 28 | D | |||||||||||||||
4/27/20 16:47 | 4/26/20 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nies Alan S | TX | D | M.d | 0 | 0.00 | 0 | 3 | 25 | 17 | D | |||||||||||||||
12/20/07 16:27 | 12/19/07 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Nies Alan S | TX | D | P | 15 | 2.98 | 0 | 5 | New | 5 | D | -19 | -12 | -10 | -8 | -11 | -11 | -12 | -4 | -1 | -2 | -15 | -26 | -38 | -53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |